FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096723 [Registered on: 31/10/2025] Trial Registered Prospectively
Last Modified On: 30/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Understanding Symptoms of Thyroid Imbalance and the effect of Ayurvedic Medicines Kanchanar Guggulu and Rasapachak Kwatha compare to Kanchanar Triphala Kwatha. 
Scientific Title of Study   A Cross-Sectional study on Rasavaha Srotodushti Lakshana in primary Hypothyroidism and evaluating the therapeutic efficacy of Kanchanar Guggulu with Rasapachak Kwatha versus Kanchanara Triphala Kwatha on Thyroid function. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Salve Arti Madhukar  
Designation  MD Scholar, Department Of Roga Nidana Evum Vikriti Vigyana  
Affiliation  All India Institute of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana,3rd floor, Academic block, Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Mathura road, New Delhi

South
DELHI
110076
India 
Phone  8767781210  
Fax    
Email  salvearti9878@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shalini Rai 
Designation  Associate Professor 
Affiliation  All India Institute of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana,3rd floor, Academic block, Block ,All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Mathura road, New Delhi

South
DELHI
110076
India 
Phone  9389423843  
Fax    
Email  vd.raishalini@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Salve Arti Madhukar  
Designation  MD Scholar, Department Of Roga Nidana Evum Vikriti Vigyana  
Affiliation  All India Institute of Ayurveda 
Address  Department of Roga Nidana Evum Vikriti Vigyana,3rd floor, Academic block, Block ,All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Mathura road, New Delhi

South
DELHI
110076
India 
Phone  8767781210  
Fax    
Email  salvearti9878@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda Sarita Vihar New Delhi 110076 
 
Primary Sponsor  
Name  All India Institute of Ayurveda 
Address  All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Mathura road, New Delhi 110076  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Salve Arti Madhukar   All India Institute of Ayurveda  Department of Roga Nidana Evum Vikriti Vigyana, OPD 8 and OPD 16 Ground floor, Hospital Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar,New Delhi 110076
South
DELHI 
8767781210

salvearti9878@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, All India Institute Of Ayurveda, New Delhi   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E039||Hypothyroidism, unspecified. Ayurveda Condition: ICD11,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Rasapachak Kwatha, Reference: Charak Chikitsa -3/200, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Kanchanar Guggulu, Reference: Bhaish.Ratnavali-Galagand rog chikitsa, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Luke warm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Kanchanara-Triphala Kwatha, Reference: Gadanigrah-Galagand rogadhikara, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Kanchanar Guggulu, Reference: Bhaish.Ratnavali-Galagand rog chikitsa,, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Luke warm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Confirmed primary hypothyroidism TSH Greater than 4.5mIU/L to less than19mIU/L, low/normal T4.
Uncontrolled hypothyroidism’s Patients.
Willing to provide written Informed consent.
Patients having Symptoms of Rasadushti in any grade
Patient having symptoms of Rasadushti last for one month
No acute illnesses

 
 
ExclusionCriteria 
Details  Secondary/tertiary hypothyroidism.
Patient with congenital hypothyroidism, goitorous hypothyroidism, transient hypothyroidism.
Pregnancy or lactation.
Comorbidities like CRF, known case of Hepatitis B, Jaundice, Tuberculosis, HIV, CAD, severe anaemia.
Patient whose symptoms are worsely aggravated after leaving the modern drug levothyroxine (for washout period of 8 days)
Mentally ill/retarded patients.
Patients with drug induced hypothyroidism, Recent thyroid surgery or radioiodine therapy within 1-year of the study.
Uncontrolled Diabetes Mellitus, hypertension.
Patient undergoing treatment for any other systemic illness.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in TSH (mIU/L)  0 and 45th days. 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in T3,T4,clinical features of hypothyroidism-Rasavaha srotodushti lakshana score  0 and 45th day.  
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Hypothyroidism is the most common endocrine disorder that affects a significant portion of the global population. The prevalence of hypothyroidism in urban India is 10.95% with a greater incidence in females and elderly persons. The thyroid gland produces two hormones, Thyroxine (T4) and Triiodothyronine (T3). The deficiency of thyroid hormone is a common condition worldwide. It affects almost all body systems and has a wide variety of clinical presentations from being asymptomatic to, in rare cases, life threatening. Ayurveda does not currently have a description of any disease condition comparable to hypothyroidism. Yet, several references are scattered in various texts. Understanding of hypothyroidism as per Ayurvedic science suggests Kapha and Meda derangements, With the involvement of Kapha, Vata dosha, along with the Srotas involved are Rasavaha, Mamsavaha, Medovaha, Purishavaha, Annavaha, Pranavaha, Manovaha, and Arthavavaha. 

NEED OF THE STUDY:
On the basis of clinical manifestation and etiological factors of hypothyroidism it may be considered primarily caused due to Derangement of Agni, Rasavaha Srotas and Medovaha Srotas as per ayurveda perspective.
Some previous studies have documented the role of Rasavaha Sroto dushti in hypothyroidism, however, to the best knowledge of the authors, none of the previous studies have used validated performa (Questionnaire) for the same, which reduces their scientific credibility. This study may provide a deeper understanding of the disease’s pathophysiology from an Ayurvedic perspective. It also helps in identifying which symptoms are most prevalent or severe in this specific population, guiding the development of more targeted interventions.

This study also plans for further confirmation of association between Rasavaha srotodushti lakshanas and hypothyroidism through the usage of Rasapachak Kwatha, which acts mainly on Rasa Dhatu. If the Rasapachak Kwatha can mitigate the symptoms of hypothyroidism it may uphold the association of Rasavaha Srotodushti lakshanas in hypothyroidism. Additionally, it may also demonstrate how Ayurvedic treatments can more effectively balance the disturbances in Rasavaha Srotas and provide a holistic approach to managing hypothyroidism.

AIM:

Examine the relationship between Rasavaha Srotodushti symptoms and hypothyroidism by comparing the therapeutic effects of Rasapachak Kwatha combined with Kanchanar Guggulu versus Kanchnara Triphala Kwatha combined with Kanchanar Guggulu, based on various subjective and objective parameters. 

OBJECTIVE:

Primary Objective:

1)    To assess the therapeutic effects of Rasapachak Kwatha combined with Kanchanar Guggulu versus Kanchnara Triphala Kwatha combined with Kanchnar Guggulu on hypothyroidism, based on thyroid function (TSH).

Secondary Objective:

1)    To compare their impact on T3, T4, and clinical symptoms of hypothyroidism 


 
Close